未分化甲状腺がん的临床试验
总计8359个结果
-
University Health Network, TorontoUniversity of British Columbia; Canadian Institutes of Health Research (CIHR); CHU de Quebec-Universite... 和其他合作者招聘中
-
Virginia Commonwealth UniversityNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)完全的
-
National Cancer Institute (NCI)完全的复发性甲状腺癌 | IVA 期滤泡性甲状腺癌 | IVA 期甲状腺乳头状癌 | IVB 期滤泡性甲状腺癌 | IVB 期乳头状甲状腺癌 | IVC 期滤泡性甲状腺癌 | IVC 期甲状腺乳头状癌美国
-
National Cancer Institute (NCI)完全的
-
Memorial Sloan Kettering Cancer Center完全的甲状腺癌,乳头状 | 甲状腺癌,滤泡性 | 甲状腺癌 | 甲状腺癌 | 甲状腺癌(滤泡细胞) | BRAF V600E 突变阳性美国
-
National Health Research Institutes, Taiwan招聘中
-
Medical University of BialystokMedical Research Agency, Poland尚未招聘
-
Olivia Newton-John Cancer Research InstituteThe Alfred; Austin Health; Peter MacCallum Cancer Centre, Australia; Royal Brisbane and Women's... 和其他合作者招聘中
-
M.D. Anderson Cancer Center招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)招聘中
-
City of Hope Medical CenterNational Cancer Institute (NCI)撤销
-
Seno Medical Instruments Inc.终止Feasibility Study for Thyroid Indication美国
-
Royal Surrey County Hospital NHS Foundation Trust完全的
-
Centre Francois BaclesseCanceropôle Nord Ouest完全的
-
Xin-Wu CuiXinhua Hospital, Shanghai Jiao Tong University School of Medicine; The Central Hospital of Lishui... 和其他合作者未知
-
Johns Hopkins UniversityM.D. Anderson Cancer Center; Genzyme, a Sanofi Company; Gustave Roussy, Cancer Campus, Grand Paris完全的
-
Medstar Health Research Institute终止